Wealthfront Advisers LLC Purchases 3,088 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Wealthfront Advisers LLC raised its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 21.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 17,442 shares of the company's stock after acquiring an additional 3,088 shares during the period. Wealthfront Advisers LLC's holdings in HCA Healthcare were worth $6,027,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the stock. Brighton Jones LLC bought a new stake in shares of HCA Healthcare during the fourth quarter worth $1,021,000. Proficio Capital Partners LLC grew its holdings in shares of HCA Healthcare by 45.5% during the fourth quarter. Proficio Capital Partners LLC now owns 745 shares of the company's stock worth $223,000 after purchasing an additional 233 shares during the last quarter. Envestnet Portfolio Solutions Inc. grew its holdings in shares of HCA Healthcare by 14.7% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,623 shares of the company's stock worth $4,689,000 after purchasing an additional 2,002 shares during the last quarter. Corient Private Wealth LLC grew its holdings in shares of HCA Healthcare by 1.0% during the fourth quarter. Corient Private Wealth LLC now owns 39,067 shares of the company's stock worth $11,724,000 after purchasing an additional 381 shares during the last quarter. Finally, Cibc World Markets Corp lifted its stake in shares of HCA Healthcare by 13.1% during the fourth quarter. Cibc World Markets Corp now owns 29,268 shares of the company's stock valued at $8,785,000 after acquiring an additional 3,383 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

NYSE:HCA traded down $1.69 during mid-day trading on Friday, hitting $360.91. 1,029,847 shares of the stock were exchanged, compared to its average volume of 1,452,577. The stock has a market capitalization of $86.82 billion, a price-to-earnings ratio of 16.05, a price-to-earnings-growth ratio of 1.25 and a beta of 1.47. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19. The firm's 50-day simple moving average is $376.24 and its 200 day simple moving average is $343.58. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. During the same period in the previous year, the firm earned $5.36 EPS. The company's quarterly revenue was up 5.7% compared to the same quarter last year. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were given a dividend of $0.72 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.80%. HCA Healthcare's dividend payout ratio is currently 12.81%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Truist Financial increased their target price on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research note on Wednesday. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Finally, Bank of America lowered HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price on the stock. in a research note on Wednesday. Eight analysts have rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $399.21.

Insider Buying and Selling

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer directly owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.